Kendall Capital Management’s Sanofi SNY Stock Holding History

Kendall Capital Management’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,540	Closed	-$219K	–	247
2026 Q1	$219K	Hold	4,540	–	–	0.04%	219
2025 Q4	$220K	Sell	4,540 -145	-3%	-$7.19K	0.05%	216
2025 Q3	$221K	Sell	4,685 -50	-1%	-$2.41K	0.05%	218
2025 Q2	$229K	Buy	4,735 +80	+2%	+$4.09K	0.06%	205
2025 Q1	$258K	Hold	4,655	–	–	0.08%	194
2024 Q4	$225K	Sell	4,655 -375	-7%	-$19.1K	0.07%	204
2024 Q3	$290K	Sell	5,030 -50	-1%	-$2.7K	0.09%	185
2024 Q2	$246K	Hold	5,080	–	–	0.08%	196
2024 Q1	$247K	Sell	5,080 -500	-9%	-$24.4K	0.08%	193
2023 Q4	$277K	Sell	5,580 -10	-0.2%	-$489	0.11%	176
2023 Q3	$300K	Buy	5,590 +1,265	+29%	+$67.4K	0.13%	156
2023 Q2	$233K	Buy	+4,325	New	+$233K	0.1%	179
2018 Q2	–	Sell	-7,200	Closed	-$289K	–	114
2018 Q1	$289K	Sell	7,200 -1,425	-17%	-$59.3K	0.25%	87
2017 Q4	$371K	Buy	+8,625	New	+$398K	0.33%	79

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Kendall Capital Management's SNY Position: Q2 2026 in Review

Kendall Capital Management sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,540 shares — an estimated $219K sold.

Kendall Capital Management first reported a position in SNY in Q4 2017 and held it in 14 quarters. The position peaked at $371K in Q4 2017. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Kendall Capital Management reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
Kendall Capital Management sold 4,540 Sanofi shares in Q2 2026, an estimated $219K.
Kendall Capital Management first reported a position in Sanofi in Q4 2017 and held it in 14 quarters.
Kendall Capital Management's Sanofi position peaked at $371K in Q4 2017.
716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kendall Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.